Automobiles Healthcare Sector

Madrigal Pharmaceuticals

Market Cap: US$6.7b

A biopharmaceutical company, focuses on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH) in the United States.

BridgeBio Pharma

Market Cap: US$6.6b

A commercial-stage biopharmaceutical company, discovers, creates, tests, and delivers transformative medicines to treat patients who suffer from genetic diseases and cancers.

Bio-Rad Laboratories

Market Cap: US$6.5b

Manufactures and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America.

Blueprint Medicines

Market Cap: US$6.4b

A precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United States and internationally.

Bruker

Market Cap: US$6.1b

Develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions in the United States, Europe, the Asia Pacific, and internationally.

Stevanato Group

Market Cap: US$6.1b

Engages in the design, production, and distribution of products and processes to provide solutions for biopharma and healthcare industries in Europe, the Middle East, Africa, North America, South America, and the Asia Pacific.

Elanco Animal Health

Market Cap: US$6.1b

An animal health company, innovates, develops, manufactures, and markets products for pets and farm animals worldwide.

Jazz Pharmaceuticals

Market Cap: US$6.1b

Jazz Pharmaceuticals plc identifies, develops, and commercializes pharmaceutical products in the United States, Europe, and internationally.

Verona Pharma

Market Cap: US$6.0b

A biopharmaceutical company, focuses on development and commercialization of therapies for the treatment of respiratory diseases with unmet medical needs.

Legend Biotech

Market Cap: US$5.9b

Through its subsidiaries, operates as a biopharmaceutical company that discovers, develops, manufactures, and commercializes novel cell therapies for oncology and other indications in the United States, China, and Europe.

Hikma Pharmaceuticals

Market Cap: UK£4.4b

Develops, manufactures, markets, and sells a range of generic, branded, and in-licensed pharmaceutical products.

Telix Pharmaceuticals

Market Cap: AU$9.1b

A commercial-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic and diagnostic radiopharmaceuticals for cancer and rare diseases in Australia, Belgium, Japan, Switzerland, and the United States.

CorVel

Market Cap: US$5.8b

Provides workers’ compensation, auto, liability, and health solutions.

Merit Medical Systems

Market Cap: US$5.7b

Designs, develops, manufactures, and markets single-use medical products for interventional, diagnostic, and therapeutic procedures in the United States and internationally.

Teleflex

Market Cap: US$5.6b

Designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide.

Lantheus Holdings

Market Cap: US$5.6b

Develops, manufactures, and commercializes diagnostic and therapeutic products that assist clinicians in diagnosis and treatment of heart, cancer, and other diseases worldwide.

Ramsay Health Care

Market Cap: AU$8.4b

Owns and operates hospitals in Australia, and internationally.

TG Therapeutics

Market Cap: US$5.4b

A commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell mediated diseases in the United States and internationally.

Axsome Therapeutics

Market Cap: US$5.4b

A biopharmaceutical company, develops and delivers novel therapies for the management of central nervous system (CNS) disorders in the United States.

LHC Group

Market Cap: US$5.3b

LHC Group, Inc., a health care provider, specializes in the post-acute continuum of care primarily for Medicare beneficiaries in the United States.

Ionis Pharmaceuticals

Market Cap: US$5.2b

A commercial-stage biotechnology company, provides RNA-targeted medicines in the United States.

Option Care Health

Market Cap: US$5.2b

Offers home and alternate site infusion services in the United States.

Glaukos

Market Cap: US$5.2b

An ophthalmic pharmaceutical and medical technology company, develops therapies for the treatment of glaucoma, corneal disorders, and retinal diseases in the United States and internationally.

Guardant Health

Market Cap: US$5.2b

A precision oncology company, provides blood and tissue tests, and data sets in the United States and internationally.

Nuvalent

Market Cap: US$5.1b

A clinical-stage biopharmaceutical company, engages in the development of therapies for patients with cancer.

ADMA Biologics

Market Cap: US$5.1b

A biopharmaceutical company, develops, manufactures, and markets specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally.

Alkermes

Market Cap: US$5.0b

A biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in therapeutic areas in the United States, Ireland, and internationally.

EBOS Group

Market Cap: NZ$7.8b

Engages in the marketing, wholesale, and distribution of healthcare, medical, pharmaceutical, and animal care products in Australia, Southeast Asia, and New Zealand.

Inspire Medical Systems

Market Cap: US$4.5b

A medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally.

iRhythm Technologies

Market Cap: US$4.4b

A digital healthcare company, engages in the design, development, and commercialization of device-based technology that provides ambulatory cardiac monitoring services to diagnose arrhythmias in the United States.

Prestige Consumer Healthcare

Market Cap: US$4.3b

Develops, manufactures, markets, distributes, and sells over the counter (OTC) health and personal care products in North America, Australia, and internationally.

RadNet

Market Cap: US$4.2b

Provides outpatient diagnostic imaging services in the United States and internationally.

Integer Holdings

Market Cap: US$4.2b

Operates as a medical device contract development and manufacturing company in the United States, Puerto Rico, Costa Rica, and internationally.

Bausch + Lomb

Market Cap: US$4.1b

Operates as an eye health company in the United States, Puerto Rico, China, France, Japan, Germany, the United Kingdom, Canada, Russia, Spain, Italy, Mexico, Poland, and internationally.

Vaxcyte

Market Cap: US$4.1b

A clinical-stage vaccine innovation company, develops conjugate and novel protein vaccines to prevent or treat bacterial infectious diseases.

Krystal Biotech

Market Cap: US$4.0b

A commercial-stage biotechnology company, discovers, develops, manufactures, and commercializes genetic medicines to treat diseases with high unmet medical needs in the United States.